乐伐替尼是一种口服，多靶点酪氨酸激酶抑制剂，抑制 VEGFR2(KDR) 和 VEGFR3(Flt-4) 的 IC50 分别为 4 和 5.2 nM，是一种抗癌药物，用于治疗某些类型的甲状腺癌，也可用于治疗其他癌症。
5-(Ethoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione
4-Amino-2-chlorobenzonitrile
4-Chloro-7-methoxyquinoline-6-carboxamide
1-(2-Chloro-4-hydroxyphenyl)-3-cyclopropylurea
4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide methanesulfonate
4-Amino-2-methoxybenzonitrile
Phenyl (2-chloro-4-hydroxyphenyl)carbamate
4-Amino-3-chlorophenol
4-(4-Amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxamide
Phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate
7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carbonitrile
7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylic acid
